Annual Gross Profit
$33.54 B
-$32.44 B-49.17%
31 December 2023
Summary:
Pfizer annual gross profit is currently $33.54 billion, with the most recent change of -$32.44 billion (-49.17%) on 31 December 2023. During the last 3 years, it has risen by +$375.00 million (+1.13%). PFE annual gross profit is now -49.17% below its all-time high of $65.99 billion, reached on 31 December 2022.PFE Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$12.44 B
+$2.46 B+24.59%
30 September 2024
Summary:
Pfizer quarterly gross profit is currently $12.44 billion, with the most recent change of +$2.46 billion (+24.59%) on 30 September 2024. Over the past year, it has increased by +$8.21 billion (+194.53%). PFE quarterly gross profit is now -34.86% below its all-time high of $19.09 billion, reached on 01 June 2022.PFE Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$39.87 B
+$8.21 B+25.95%
30 September 2024
Summary:
Pfizer TTM gross profit is currently $39.87 billion, with the most recent change of +$8.21 billion (+25.95%) on 30 September 2024. Over the past year, it has dropped by -$2.36 billion (-5.60%). PFE TTM gross profit is now -39.58% below its all-time high of $65.99 billion, reached on 31 December 2022.PFE TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.2% | +194.5% | -5.6% |
| 3 y3 years | +1.1% | -11.8% | -11.6% |
| 5 y5 years | +5.3% | +23.4% | +25.4% |
PFE Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -49.2% | +1.1% | -34.9% | +194.5% | -39.6% | +26.8% |
| 5 y | 5 years | -49.2% | +5.3% | -34.9% | +788.4% | -39.6% | +54.2% |
| alltime | all time | -49.2% | +1264.9% | -34.9% | +3547.5% | -39.6% | +3740.9% |
Pfizer Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.44 B(+24.6%) | $39.87 B(+26.0%) |
| June 2024 | - | $9.98 B(-13.2%) | $31.65 B(+0.7%) |
| Mar 2024 | - | $11.50 B(+93.3%) | $31.44 B(-6.3%) |
| Dec 2023 | $33.54 B(-49.2%) | $5.95 B(+40.9%) | $33.54 B(-20.6%) |
| Sept 2023 | - | $4.22 B(-56.8%) | $42.23 B(-22.6%) |
| June 2023 | - | $9.77 B(-28.2%) | $54.59 B(-14.6%) |
| Mar 2023 | - | $13.60 B(-7.1%) | $63.91 B(-3.1%) |
| Dec 2022 | $65.99 B(+30.8%) | $14.64 B(-11.7%) | $65.99 B(+0.8%) |
| Sept 2022 | - | $16.57 B(-13.2%) | $65.45 B(+3.9%) |
| June 2022 | - | $19.09 B(+21.8%) | $62.98 B(+12.9%) |
| Mar 2022 | - | $15.68 B(+11.2%) | $55.78 B(+10.5%) |
| Dec 2021 | $50.47 B(+52.2%) | $14.10 B(-0.0%) | $50.47 B(+11.9%) |
| Sept 2021 | - | $14.10 B(+18.5%) | $45.08 B(+14.9%) |
| June 2021 | - | $11.90 B(+14.9%) | $39.25 B(+10.9%) |
| Mar 2021 | - | $10.36 B(+18.9%) | $35.38 B(+6.7%) |
| Dec 2020 | $33.17 B(+1.0%) | $8.72 B(+5.4%) | $33.17 B(+28.3%) |
| Sept 2020 | - | $8.27 B(+2.9%) | $25.85 B(-6.5%) |
| June 2020 | - | $8.04 B(-1.3%) | $27.66 B(-8.7%) |
| Mar 2020 | - | $8.14 B(+481.6%) | $30.31 B(-7.7%) |
| Dec 2019 | $32.85 B(+3.2%) | $1.40 B(-86.1%) | $32.85 B(+3.3%) |
| Sept 2019 | - | $10.08 B(-5.7%) | $31.79 B(-1.6%) |
| June 2019 | - | $10.69 B(+0.0%) | $32.32 B(+0.4%) |
| Mar 2019 | - | $10.69 B(+3033.4%) | $32.18 B(+1.1%) |
| Dec 2018 | $31.84 B(-22.9%) | $341.00 M(-96.8%) | $31.84 B(-24.1%) |
| Sept 2018 | - | $10.60 B(+0.5%) | $41.94 B(+0.7%) |
| June 2018 | - | $10.55 B(+2.0%) | $41.66 B(+0.8%) |
| Mar 2018 | - | $10.34 B(-1.0%) | $41.35 B(+0.1%) |
| Dec 2017 | $41.32 B(+2.0%) | $10.45 B(+1.2%) | $41.32 B(+0.1%) |
| Sept 2017 | - | $10.32 B(+0.9%) | $41.29 B(+0.9%) |
| June 2017 | - | $10.24 B(-0.7%) | $40.92 B(+0.6%) |
| Mar 2017 | - | $10.31 B(-1.0%) | $40.66 B(+0.4%) |
| Dec 2016 | $40.50 B(+3.3%) | $10.42 B(+4.6%) | $40.50 B(-0.5%) |
| Sept 2016 | - | $9.96 B(-0.1%) | $40.72 B(+0.2%) |
| June 2016 | - | $9.97 B(-1.8%) | $40.63 B(+0.7%) |
| Mar 2016 | - | $10.15 B(-4.5%) | $40.33 B(+2.9%) |
| Dec 2015 | $39.20 B(-2.1%) | $10.64 B(+7.8%) | $39.20 B(+0.6%) |
| Sept 2015 | - | $9.87 B(+2.0%) | $38.98 B(-0.3%) |
| June 2015 | - | $9.67 B(+7.2%) | $39.11 B(-1.6%) |
| Mar 2015 | - | $9.03 B(-13.3%) | $39.75 B(-0.7%) |
| Dec 2014 | $40.03 B(-4.7%) | $10.42 B(+4.2%) | $40.03 B(-0.9%) |
| Sept 2014 | - | $9.99 B(-3.1%) | $40.38 B(-0.9%) |
| June 2014 | - | $10.31 B(+10.8%) | $40.74 B(-1.0%) |
| Mar 2014 | - | $9.31 B(-13.5%) | $41.16 B(-2.0%) |
| Dec 2013 | $42.00 B(-6.3%) | $10.76 B(+3.9%) | $42.00 B(-0.9%) |
| Sept 2013 | - | $10.36 B(-3.5%) | $42.37 B(-0.7%) |
| June 2013 | - | $10.73 B(+5.8%) | $42.66 B(-2.0%) |
| Mar 2013 | - | $10.15 B(-8.9%) | $43.52 B(-4.4%) |
| Dec 2012 | $44.84 B(-7.6%) | $11.14 B(+4.6%) | $45.51 B(+2.9%) |
| Sept 2012 | - | $10.64 B(-8.2%) | $44.24 B(-5.5%) |
| June 2012 | - | $11.59 B(-4.5%) | $46.80 B(-2.7%) |
| Mar 2012 | - | $12.14 B(+23.0%) | $48.12 B(-1.4%) |
| Dec 2011 | $48.53 B(-3.7%) | $9.87 B(-25.3%) | $48.79 B(-4.8%) |
| Sept 2011 | - | $13.20 B(+2.2%) | $51.27 B(+2.0%) |
| June 2011 | - | $12.91 B(+0.8%) | $50.28 B(-1.1%) |
| Mar 2011 | - | $12.81 B(+3.7%) | $50.81 B(+0.9%) |
| Dec 2010 | $50.38 B(+22.5%) | $12.35 B(+1.2%) | $50.38 B(-0.5%) |
| Sept 2010 | - | $12.21 B(-9.2%) | $50.63 B(+4.9%) |
| June 2010 | - | $13.45 B(+8.7%) | $48.26 B(+9.6%) |
| Mar 2010 | - | $12.37 B(-1.8%) | $44.04 B(+7.1%) |
| Dec 2009 | $41.12 B(+2.3%) | $12.60 B(+28.2%) | $41.12 B(+5.0%) |
| Sept 2009 | - | $9.83 B(+6.5%) | $39.15 B(-0.0%) |
| June 2009 | - | $9.23 B(-2.4%) | $39.17 B(-1.5%) |
| Mar 2009 | - | $9.46 B(-11.0%) | $39.78 B(-1.0%) |
| Dec 2008 | $40.18 B(+8.1%) | $10.63 B(+7.9%) | $40.18 B(+1.0%) |
| Sept 2008 | - | $9.85 B(+0.1%) | $39.80 B(+6.6%) |
| June 2008 | - | $9.84 B(-0.2%) | $37.32 B(+2.4%) |
| Mar 2008 | - | $9.86 B(-3.7%) | $36.45 B(-2.0%) |
| Dec 2007 | $37.18 B(-8.7%) | $10.24 B(+39.0%) | $37.18 B(-0.4%) |
| Sept 2007 | - | $7.37 B(-17.9%) | $37.32 B(-7.3%) |
| June 2007 | - | $8.97 B(-15.2%) | $40.27 B(-2.4%) |
| Mar 2007 | - | $10.59 B(+1.9%) | $41.24 B(+1.3%) |
| Dec 2006 | $40.73 B | $10.39 B(+0.7%) | $40.73 B(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2006 | - | $10.32 B(+3.7%) | $40.91 B(+1.7%) |
| June 2006 | - | $9.95 B(-1.2%) | $40.24 B(+0.7%) |
| Mar 2006 | - | $10.08 B(-4.6%) | $39.98 B(-2.0%) |
| Dec 2005 | $40.17 B(-5.7%) | $10.56 B(+9.5%) | $40.81 B(+0.9%) |
| Sept 2005 | - | $9.65 B(-0.4%) | $40.43 B(-3.7%) |
| June 2005 | - | $9.69 B(-11.1%) | $41.97 B(-1.9%) |
| Mar 2005 | - | $10.90 B(+7.0%) | $42.80 B(+0.5%) |
| Dec 2004 | $42.60 B(+21.2%) | $10.19 B(-9.0%) | $42.59 B(-1.2%) |
| Sept 2004 | - | $11.19 B(+6.4%) | $43.12 B(+5.2%) |
| June 2004 | - | $10.52 B(-1.6%) | $40.99 B(+6.8%) |
| Mar 2004 | - | $10.69 B(-0.2%) | $38.39 B(+9.2%) |
| Dec 2003 | $35.15 B(+24.3%) | $10.72 B(+18.2%) | $35.16 B(+8.0%) |
| Sept 2003 | - | $9.06 B(+14.4%) | $32.55 B(+6.9%) |
| June 2003 | - | $7.92 B(+6.2%) | $30.46 B(+5.3%) |
| Mar 2003 | - | $7.46 B(-8.0%) | $28.93 B(+2.3%) |
| Dec 2002 | $28.28 B(+12.2%) | $8.11 B(+16.3%) | $28.28 B(+9.2%) |
| Sept 2002 | - | $6.97 B(+9.0%) | $25.89 B(+1.3%) |
| June 2002 | - | $6.39 B(-6.1%) | $25.57 B(-0.6%) |
| Mar 2002 | - | $6.81 B(+18.9%) | $25.71 B(+1.5%) |
| Dec 2001 | $25.20 B(+3.5%) | $5.72 B(-13.9%) | $25.33 B(-3.6%) |
| Sept 2001 | - | $6.65 B(+1.7%) | $26.28 B(+2.8%) |
| June 2001 | - | $6.54 B(+1.8%) | $25.57 B(+2.9%) |
| Mar 2001 | - | $6.42 B(-3.8%) | $24.84 B(+1.0%) |
| Dec 2000 | $24.35 B(+7.2%) | $6.68 B(+12.5%) | $24.59 B(+1.8%) |
| Sept 2000 | - | $5.94 B(+2.2%) | $24.16 B(+2.6%) |
| June 2000 | - | $5.81 B(-5.8%) | $23.53 B(+1.5%) |
| Mar 2000 | - | $6.17 B(-1.1%) | $23.18 B(+13.0%) |
| Dec 1999 | $22.71 B(+19.4%) | $6.24 B(+17.4%) | $20.52 B(-16.5%) |
| Sept 1999 | - | $5.32 B(-2.5%) | $24.57 B(+10.2%) |
| June 1999 | - | $5.45 B(+55.4%) | $22.29 B(+12.6%) |
| Mar 1999 | - | $3.51 B(-65.9%) | $19.80 B(+4.2%) |
| Dec 1998 | $19.02 B(+95.9%) | $10.29 B(+239.5%) | $19.00 B(+67.3%) |
| Sept 1998 | - | $3.03 B(+2.4%) | $11.36 B(+5.4%) |
| June 1998 | - | $2.96 B(+9.3%) | $10.78 B(+4.1%) |
| Mar 1998 | - | $2.71 B(+2.3%) | $10.35 B(+1.4%) |
| Dec 1997 | $9.71 B(+13.8%) | $2.65 B(+8.1%) | $10.21 B(+11.1%) |
| Sept 1997 | - | $2.45 B(-3.2%) | $9.19 B(+0.8%) |
| June 1997 | - | $2.53 B(-1.5%) | $9.12 B(+3.3%) |
| Mar 1997 | - | $2.57 B(+57.8%) | $8.83 B(+3.5%) |
| Dec 1996 | $8.53 B(+3.6%) | $1.63 B(-31.6%) | $8.53 B(-7.1%) |
| Sept 1996 | - | $2.38 B(+6.1%) | $9.18 B(+3.6%) |
| June 1996 | - | $2.25 B(-1.1%) | $8.86 B(+3.2%) |
| Mar 1996 | - | $2.27 B(-0.6%) | $8.59 B(+3.7%) |
| Dec 1995 | $8.23 B(+23.7%) | $2.28 B(+10.8%) | $8.28 B(+5.8%) |
| Sept 1995 | - | $2.06 B(+4.8%) | $7.83 B(+5.3%) |
| June 1995 | - | $1.97 B(+0.1%) | $7.44 B(+6.3%) |
| Mar 1995 | - | $1.97 B(+7.4%) | $7.00 B(+5.2%) |
| Dec 1994 | $6.65 B(+11.6%) | $1.83 B(+9.7%) | $6.65 B(+3.9%) |
| Sept 1994 | - | $1.67 B(+9.2%) | $6.40 B(+2.7%) |
| June 1994 | - | $1.53 B(-5.7%) | $6.23 B(+2.5%) |
| Mar 1994 | - | $1.62 B(+2.6%) | $6.08 B(+1.9%) |
| Dec 1993 | $5.96 B(+9.0%) | $1.58 B(+5.4%) | $5.96 B(+1.6%) |
| Sept 1993 | - | $1.50 B(+9.1%) | $5.87 B(+2.2%) |
| June 1993 | - | $1.37 B(-8.7%) | $5.74 B(+2.0%) |
| Mar 1993 | - | $1.51 B(+1.1%) | $5.63 B(+3.0%) |
| Dec 1992 | $5.47 B(+9.5%) | $1.49 B(+8.5%) | $5.47 B(+3.7%) |
| Sept 1992 | - | $1.37 B(+8.6%) | $5.27 B(+1.6%) |
| June 1992 | - | $1.26 B(-5.7%) | $5.19 B(+1.8%) |
| Mar 1992 | - | $1.34 B(+3.4%) | $5.10 B(+2.2%) |
| Dec 1991 | $4.99 B(+14.2%) | $1.30 B(+0.5%) | $4.99 B(+2.2%) |
| Sept 1991 | - | $1.29 B(+9.9%) | $4.88 B(+3.5%) |
| June 1991 | - | $1.17 B(-4.6%) | $4.72 B(+3.4%) |
| Mar 1991 | - | $1.23 B(+3.7%) | $4.57 B(+4.4%) |
| Dec 1990 | $4.37 B(+14.5%) | $1.19 B(+5.4%) | $4.37 B(+37.3%) |
| Sept 1990 | - | $1.13 B(+10.6%) | $3.18 B(+54.8%) |
| June 1990 | - | $1.02 B(-1.8%) | $2.06 B(+98.2%) |
| Mar 1990 | - | $1.04 B | $1.04 B |
| Dec 1989 | $3.82 B(+7.2%) | - | - |
| Dec 1988 | $3.56 B(+11.8%) | - | - |
| Dec 1987 | $3.18 B(+9.7%) | - | - |
| Dec 1986 | $2.90 B(+11.3%) | - | - |
| Dec 1985 | $2.61 B(+6.1%) | - | - |
| Dec 1984 | $2.46 B | - | - |
FAQ
- What is Pfizer annual gross profit?
- What is the all time high annual gross profit for Pfizer?
- What is Pfizer annual gross profit year-on-year change?
- What is Pfizer quarterly gross profit?
- What is the all time high quarterly gross profit for Pfizer?
- What is Pfizer quarterly gross profit year-on-year change?
- What is Pfizer TTM gross profit?
- What is the all time high TTM gross profit for Pfizer?
- What is Pfizer TTM gross profit year-on-year change?
What is Pfizer annual gross profit?
The current annual gross profit of PFE is $33.54 B
What is the all time high annual gross profit for Pfizer?
Pfizer all-time high annual gross profit is $65.99 B
What is Pfizer annual gross profit year-on-year change?
Over the past year, PFE annual gross profit has changed by -$32.44 B (-49.17%)
What is Pfizer quarterly gross profit?
The current quarterly gross profit of PFE is $12.44 B
What is the all time high quarterly gross profit for Pfizer?
Pfizer all-time high quarterly gross profit is $19.09 B
What is Pfizer quarterly gross profit year-on-year change?
Over the past year, PFE quarterly gross profit has changed by +$8.21 B (+194.53%)
What is Pfizer TTM gross profit?
The current TTM gross profit of PFE is $39.87 B
What is the all time high TTM gross profit for Pfizer?
Pfizer all-time high TTM gross profit is $65.99 B
What is Pfizer TTM gross profit year-on-year change?
Over the past year, PFE TTM gross profit has changed by -$2.36 B (-5.60%)